Press Releases

Alfa Chemistry Expands Offering of Polymer Fibers: Polyester Fiber, Polyamide Fiber, Aromatic Polyamide Fiber, and Polyacrylonitrile Fiber

ENPICOM secures financing from BOP Capital, BOM Brabant Ventures and brings Dr. Colby Souders on board as a new investor

Investment to bolster international partnerships and advance AI-driven solutions for antibody discovery

ReciBioPharm and GeneVentiv Therapeutics partner to advance first AAV-based gene therapy for haemophilia patients with inhibitors

ReciBioPharm and GeneVentiv Therapeutics partner to accelerate AAV-based gene therapy for haemophilia patients

Alfa Chemistry’s MS and NMR Center Enables Fast, Cost-Effective Laboratory Analytical Testing

CD Formulation Incorporates Phase Separation Method for Microsphere Production

CD Formulation Offers Accurate and Reliable Impurity Determination for Biopharmaceutical Studies

Alfa Chemistry Adds to Its Lineup of Derivatization Reagents for High-Performance Liquid Chromatography (HPLC)

Hovione and GEA Strengthen Partnership to Advance Continuous Tableting Technology

Lindus Health Introduces Comprehensive “All-In-One CRO” Package for CNS, Neurology, and Psychiatric Clinical Trials

Lindus Health Introduces Comprehensive “All-In-One CRO” Package for CNS, Neurology, and Psychiatric Clinical Trials

Dr. Vince Clinical Research Announces First Dosing in a Phase II Study in Patients With Depression

Don't Miss: Huateng Pharma's Exhibit at CPHI Japan 2024

Hunan Huateng Pharmaceutical Co., Ltd is set to present its groundbreaking solutions at CPHI Japan 2024, showcasing expertise in PEG derivatives and CDMO services. Attendees are encouraged to visit Booth No. 4X-08 to explore cutting-edge offerings and engage with industry experts.

Join Biopharma PEG Scientific Inc. at PEGS Boston Summit and TIDES USA 2024

Biopharma PEG Scientific Inc. will showcase its latest high-purity polyethylene glycol (PEG) derivatives and custom synthesis solutions at Booth No. 718 in PEGS Boston Summit 2024 and at TIDES USA 2024 at Booth No. 935.

New Syngene biologics manufacturing facility to be operational for US and European customers from mid-year

New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day

Quotient Sciences Strengthens Its Top Team with Three New Appointments

NOTTINGHAM, UK; 18 March 2024 – Drug development and manufacturing accelerator Quotient Sciences has announced major changes to its commercial and scientific executive leadership team, strengthening its position as a global leader in the sector.

SunWay Biotech and Gnosis by Lesaffre Form Alliance to Launch MenaQ7® Metabolic, featuring the ANKASCIN® 568-R ingredient

Veramed appoints Karen Curran as Chief Strategy Officer

Specialist Biometrics CRO, Veramed has announced the appointment of Karen Curran as Chief Strategy Officer.

LogiPharma Delivers Diversity, Equity, and Inclusion as a Key Theme for 2024

To mark International Women’s Day, LogiPharma, the largest global event for life sciences supply chain professionals, has reinforced its commitment to diversity, equity, and inclusion (DE&I) as one of the key themes for this year's conference.

Catawba Research Appoints Julie Arnold as New Head of Project Management to Drive Growth and Innovation

Catawba Research today introduced Julie Arnold as its vice president of project management.

Catawba Research Appoints Syed Faridi as New Head of Business Development

Catawba Research welcomes Syed Faridi as its Vice President of Global Business Development.

Empros Pharma edges closer to filling the gap in the market for safe and effective oral weight management treatment

Swedish biopharma company reports positive topline data for phase 2b trial of weight management treatment with responders demonstrating up to 23% in weight loss